Core Viewpoint - Liyang Chip (688135.SH) reported a revenue of 284 million yuan for the first half of 2025, marking a year-on-year increase of 23.09%, while the net profit attributable to shareholders was a loss of 7.06 million yuan, an improvement from the previous year's loss of 8.44 million yuan [1][2]. Financial Performance - Revenue for the first half of 2025 was 284,036,747.38 yuan, up 23.09% from 230,754,593.03 yuan in the same period last year [2]. - The total profit for the period was a loss of 8,946,556.63 yuan, compared to a loss of 16,374,304.03 yuan in the previous year [2]. - The net profit attributable to shareholders was a loss of 7,061,056.54 yuan, improving from a loss of 8,444,249.31 yuan year-on-year [2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of 6,759,610.05 yuan, compared to a loss of 7,983,544.97 yuan in the previous year [2]. - The net cash flow from operating activities was 100,788,676.45 yuan, down 9.40% from 111,240,850.65 yuan in the previous year [2]. Asset and Equity Position - As of the end of the reporting period, the net assets attributable to shareholders were 1,126,888,476.08 yuan, an increase of 1.82% from 1,106,774,363.80 yuan at the end of the previous year [2]. - Total assets amounted to 2,610,392,643.05 yuan, reflecting a slight increase of 0.68% from 2,592,747,635.77 yuan at the end of the previous year [2]. Historical Context - Liyang Chip was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 11, 2020, with an initial public offering of 34.1 million shares, representing 25% of the total share capital post-issue, at a price of 15.72 yuan per share [3]. - The total funds raised during the IPO amounted to 536.05 million yuan, with a net amount of 470.94 million yuan after deducting issuance costs [3]. Recent Financing Activities - On July 17, 2024, Liyang Chip announced the issuance of convertible bonds, raising a total of 520 million yuan (including issuance costs), with a net amount of 512.89 million yuan after deducting underwriting fees [4]. - The total amount raised from the two financing activities (IPO and convertible bonds) is 1.056 billion yuan [5].

Summary of Key Points Core Viewpoint - The announcement details the shareholding structure and the results of the share reduction plans by key shareholders of Guangdong Liyang Chip Testing Co., Ltd, highlighting the completion of the planned share reductions and the current holdings of the shareholders [1][2][3][4]. Shareholding Structure - Key shareholder and core technical personnel Mr. Lu Xukun holds 272,073 shares, accounting for 0.1340% of the total share capital [1]. - Key shareholder and core technical personnel Mr. Zheng Chaosheng holds 120,698 shares, accounting for 0.0595% of the total share capital [1]. - Shareholder and director Mr. Qu Hao holds 7,181,680 shares, accounting for 3.5376% of the total share capital [1][3]. Share Reduction Plans - Mr. Lu Xukun planned to reduce his holdings by up to 250,000 shares (0.1231% of total shares) [1]. - Mr. Zheng Chaosheng planned to reduce his holdings by up to 58,000 shares (0.0286% of total shares) [1]. - Mr. Qu Hao planned to reduce his holdings by up to 1,600,000 shares (0.7881% of total shares) [1]. Implementation Results - Mr. Lu Xukun completed the reduction of 250,000 shares at a price range of 30.66 to 31.14 CNY per share, totaling approximately 7.72 million CNY [3][4]. - Mr. Zheng Chaosheng completed the reduction of 58,000 shares at a price range of 29.40 to 31.15 CNY per share, totaling approximately 1.73 million CNY [3][4]. - Mr. Qu Hao completed the reduction of 1,600,000 shares at a price range of 29.64 to 33.01 CNY per share, totaling approximately 48.77 million CNY [4].

Fundraising Overview - The company has been approved to issue convertible bonds totaling RMB 52 million, with a term of 6 years, and has successfully raised the full amount [2] - After deducting issuance costs of approximately RMB 7.11 million, the net amount raised is approximately RMB 51.29 million, which was fully received by July 8, 2024 [2] Fund Management - The company has established a fundraising management system in compliance with relevant regulations to protect the rights of small investors [3] - A tripartite supervision agreement has been signed with the project subsidiary and the sponsoring institution to ensure proper use of the raised funds [4][5] Special Account Management - The company has opened special accounts for the raised funds, with specific banks involved in the management of these accounts [6] - The company has decided to close the special accounts at two banks as the funds have been fully utilized, and the remaining interest will be transferred to the company's main account for working capital [8]

Core Viewpoint - Liyang Chip's 2025 semi-annual report indicates strong growth in integrated circuit testing revenue, driven by high demand and new customer product launches [1][2]. Group 1: Financial Performance - In the first half of 2025, Liyang Chip's revenue from integrated circuit testing reached 277 million yuan, a year-on-year increase of 21.85% [1]. - The second quarter saw record revenue of 150 million yuan, up 32.03% year-on-year, and a net profit of 523,400 yuan, reflecting a 105.96% increase [1]. - The company's profitability improved significantly in the second quarter after a challenging first quarter, with revenue increasing sequentially [1]. Group 2: Strategic Initiatives - The "One Body, Two Wings" strategy has begun to show results, focusing on integrated circuit testing while enhancing operational efficiency [2]. - The company has developed a comprehensive service chain covering wafer thinning, laser grooving, and stealth dicing, improving chip yield and reliability [2]. - The wafer thinning business achieved revenue of 6.75 million yuan in the first half of 2025, a substantial increase of 111.61% year-on-year [2]. Group 3: Collaborative Efforts - Liyang Chip has established an exclusive partnership with Azoteq to provide heterogeneous wafer stacking and testing services [3]. - The "TerraSight" project, developed in collaboration with Azoteq, successfully demonstrated its technology in July 2025, with plans for further testing in the second half of 2025 [3]. - The ongoing implementation of the "One Body, Two Wings" strategy positions Liyang Chip to maintain a leading edge in the integrated circuit testing sector, supporting the development of the domestic chip industry [3].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expectation of stock price appreciation exceeding 15% over the next six months [5]. Core Insights - The company achieved record-high revenue in Q2 2025, driven by strong downstream demand from the smart driving and AI sectors, alongside proactive capacity expansion [2][3]. - The significant increase in net profit growth (831.03% YoY) outpaced revenue growth (47.53% YoY), showcasing operational leverage [2]. - The gross margin improved to 34.50%, up 5.94 percentage points YoY, primarily due to enhanced capacity utilization, which currently stands at 90% [2]. - The company is strategically investing in advanced packaging and testing capabilities to meet the rising demand for chip testing, particularly in 2.5D/3D and Chiplet technologies [3]. Financial Summary - For H1 2025, the company reported revenue of 634 million yuan and a net profit of 101 million yuan, with Q2 revenue reaching 349 million yuan [1]. - The revenue breakdown for different business segments includes wafer testing (355 million yuan), chip product testing (254 million yuan), and other businesses (29 million yuan), with respective YoY growth rates of 49.32%, 71.57%, and -38.36% [2]. - The company forecasts net profits of 274 million yuan, 373 million yuan, and 506 million yuan for 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 44, 32, and 24 [3].

Core Viewpoint - The company has released its 2025 semi-annual report, detailing its operational results, financial status, and future development plans, emphasizing the importance of reviewing the full report for comprehensive understanding [1][10]. Group 1: Company Overview - The company is Guangdong Liyang Chip Testing Co., Ltd., with stock code 688135 and convertible bond code 118048 [6][19]. - The company held its 11th board meeting on August 25, 2025, with all directors present, ensuring compliance with relevant laws and regulations [7][8]. Group 2: Financial Data - The company raised a total of RMB 520 million through the issuance of convertible bonds, with a net amount of RMB 512.89 million after deducting issuance costs [20][21]. - The company has established a dedicated account for managing the raised funds, in compliance with regulatory requirements [22][23]. Group 3: Fund Management and Usage - The company has implemented a fund management system to ensure the efficient use of raised funds, including a tripartite supervision agreement with banks and the sponsor [22][23]. - As of June 30, 2025, the company has not used idle funds for temporary working capital or for repaying bank loans [27][29]. - The company has approved the use of up to RMB 20 million of idle funds for cash management, investing in low-risk financial products [28]. Group 4: Board and Supervisory Committee Resolutions - The board and supervisory committee have both approved the semi-annual report and the special report on the management and actual use of raised funds, confirming the accuracy and completeness of the information disclosed [36][38].

Group 1 - The supervisory board of Guangdong Liyang Chip Testing Co., Ltd. confirmed that the 2025 semi-annual report was prepared and reviewed in compliance with relevant laws, regulations, and internal management systems [1][2] - The content and format of the 2025 semi-annual report meet the requirements of the Shanghai Stock Exchange, accurately reflecting the company's disclosed information without any false records or misleading statements [1][2] - The supervisory board unanimously agreed that the management and actual use of the raised funds for the first half of 2025 complied with the relevant regulations and that the funds were stored and used specifically for their intended purpose [2]

Company Overview - Guangdong Liyang Chip Testing Co., Ltd. is listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board with the stock code 688135 [2] - The company reported total assets of approximately CNY 2.61 billion at the end of the reporting period, reflecting a 0.68% increase from the previous year [2] - The net assets attributable to shareholders increased by 1.82% to approximately CNY 1.13 billion [2] Financial Performance - The company's operating revenue for the reporting period was approximately CNY 284 million, representing a 23.09% increase compared to the same period last year [2] - The total profit for the period was a loss of approximately CNY 8.95 million, an improvement from a loss of CNY 16.37 million in the previous year [2] - The net profit attributable to shareholders was a loss of approximately CNY 7.06 million, compared to a loss of CNY 8.44 million in the same period last year [2] - The net cash flow from operating activities was approximately CNY 100.79 million, down 9.40% from the previous year [2] - The weighted average return on net assets improved to -0.64%, up from -0.76% [2] Shareholder Information - The total number of shareholders at the end of the reporting period was 15,099 [2] - The largest shareholder, Huang Jiang, holds 29.61% of the shares, amounting to approximately 59.95 million shares [5] - Other significant shareholders include Qu Hao with 3.55% and Zhang Liping with 3.07% [5]

Group 1 - The core point of the announcement is that Liyang Chip reported a revenue of 284 million yuan in the first half of 2025, representing a year-on-year growth of 23.09% [1] - The net profit attributable to shareholders of the listed company was -7.0611 million yuan, compared to -8.4442 million yuan in the same period last year, indicating an improvement in financial performance [1]

Core Viewpoint - Weic Technology (688372) reported strong financial performance for the first half of 2025, with significant increases in revenue and net profit, indicating robust growth and improved profitability metrics [1]. Financial Performance - Total revenue reached 634 million yuan, a year-on-year increase of 47.53% [1] - Net profit attributable to shareholders was 101 million yuan, up 831.03% year-on-year [1] - Gross margin improved to 34.5%, reflecting a 20.8% increase compared to the previous year [1] - Net margin rose to 15.94%, showing a substantial increase of 531.08% year-on-year [1] - Operating cash flow per share increased by 28.11% to 2.29 yuan [1] Key Financial Metrics - The company reported a total of 9085.48 million yuan in combined sales, management, and financial expenses, which accounted for 14.32% of revenue, a decrease of 1.15% year-on-year [1] - Earnings per share surged to 0.68 yuan, marking a 580.0% increase [1] - Cash and cash equivalents increased by 240.11% to 608 million yuan [1] - Interest-bearing liabilities rose significantly by 184.68% to 2.977 billion yuan [1] Changes in Assets and Liabilities - The company experienced a 275.6% increase in receivables financing due to higher credit-rated bank acceptance bills [2] - Inventory decreased by 31.42% due to reduced turnover materials [2] - The company’s intangible assets increased by 113.19% due to the acquisition of land use rights for a new headquarters [3] Operational Insights - The company’s revenue growth was driven by increased testing demand and improved capacity utilization [4] - The company plans to focus on high-end chip testing and reliability testing, aiming to capture growth opportunities in emerging industries [10][12] - The company’s return on invested capital (ROIC) was reported at 4.33%, indicating a need for improved capital efficiency [5] Market Position and Investor Interest - The company is held by notable fund managers, with increased positions in several funds, indicating strong investor interest [6][7] - The company’s stock price has been affected by broader market conditions, but operational performance remains stable [11]